March 4, 2021 I Sports Data Labs, Inc. (SD Labs), an award-winning leader in collection, analysis, and distribution of data from sensors and sensing systems, announced today that it has added Scott Dylla, Ph.D. to its advisory board. Scott was co-founder and Chief Scientific Officer of Stemcentrx, which pioneered cancer stem cell-targeted drug discovery and development and was acquired by AbbVie for $6.2B in 2016. During his time at Stemcentrx, Scott was recognized by Business Insider as one of Silicon Valley’s Top 100 in Tech (#10).
“We are ecstatic to welcome Scott to our advisory team,” said Mark Gorski, Co-Founder and CEO of SD Labs. “Scott’s experience building and scaling up companies, as well as his experiences utilizing a variety of biological-based data sets to drive pioneering research and products, will be a huge asset for us as we continue to grow our business and define use cases and strategies for our Human Data Marketplace™ and other proprietary technologies.”
Scott currently serves as a board member of 3DBio Therapeutics, a biologics and bioprinting company with a focus on regenerative medicine that manufactures living tissues to allow replacement of each individual patient's parts with tissues designed and created specifically for them, and chairman of Chimera Bioengineering, a cell-based therapeutics company leveraging its RNA-based gene regulatory systems for chimeric antigen receptor (CAR) T-cell therapeutics with greater efficacy and superior safety for cancer patients. Scott previously trained as a postdoctoral scholar at Stanford where he was awarded American Cancer Society and Stanford Immunology fellowships, and was recognized by the British Council as one of eight outstanding young US-based researchers in the field of stem cell biology.
"I've been following SDL for a number of years and the extensibility of their technology to other verticals has never been more apparent,” said Scott Dylla. “I’m excited to work with the SD Labs team and help them develop new opportunities.”
About Sports Data Labs, Inc.
Sports Data Labs, Inc. (SD Labs) provides technology that enables interoperability of sensors and sensing systems, while using artificial intelligence to transform collected data into metrics, insights and predictions for various real-time and on-demand use cases. SD Labs technologies are supported by 17 U.S. patent applications which span across a wide range of novel systems and methods related to data collection, synthetic data generation, artificial intelligence-based predictions, sensor communication, signal processing techniques, remote communication networks, and sensor data monetization for the sports betting and digital health ecosystems. SD Labs operates in professional sports via Sports Data Labs and in the digital health ecosystem via Human Data Labs. For further information, please visit: www.sportsdatalabs.com and www.humandatalabs.com